BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 11778489)

  • 1. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J; Zhao Q; Yao H
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H; Ina Y; Ito S; Sato S; Sugiura Y; Tomita H; Ogisu N; Takada K; Yamamoto M; Morishita M; Yoshikawa K
    Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
    Liu G; Li C; Zhong X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of atrial natriuretic peptide in differentiating benign and malignant pleural effusion].
    Dong L; Li X; Sun H; Gao Q; Yang F; Fang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):147-9. PubMed ID: 11812366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
    Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
    Lin M; Meng X
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):245-8. PubMed ID: 11601213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP; Hu CP; Yang HZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
    Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
    Tian RX; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
    Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
    Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
    Zhang D; Li J; Jiang Z; Yu B; Tang X
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J; Marik PE; Levine JS;
    Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of cytokine measurement in pleural effusion].
    Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S
    Kekkaku; 1997 Oct; 72(10):565-72. PubMed ID: 9386355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.